Enrolling Now

Enrolling Now

Combined medications for those with

Type 2 Diabetes, Hypertension, and Cardiovascular Disease 

  • A study  to evaluate efficacy and safety of the combined use of oral vicadrostat and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

    • Participants with medical history of hypertension and on active pharmacological treatment

    • Participants with medical history of T2DM and on active pharmacological treatment

    • Established CV disease and on active pharmacological treatment.

      • Established cardiovascular disease includes at least one of the following: coronary artery disease, or peripheral artery disease, or cerebrovascular disease 

    Further qualifications may apply.

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

Close-up of an elderly person's hand dispensing pills from an orange bottle onto the palm of their other hand on a gray cracked surface.

Think you may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.